Lanthanum carbonate hydrate

碳酸镧

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLanthanum carbonate hydrate
Drug Alias Name水合碳酸镧Lanthanum sesquicarbonatelanthanum carbonateFoznolFosrenol +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphates binders
TargetsPhosphates
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)HyperphosphatemiaCalciphylaxis +[8] 
Global Approved IndicationsHyperphosphatemia
Approved Indications in ChinaHyperphosphatemia
Original Approved Country/TerritorySweden
Original Approved Date2004/03/19
Country/TerritoryCzechiaBelgiumUnited States +[18] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofiGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceuticals USA IncUnicycive Therapeutics IncShire Pharmaceuticals Ireland Ltd +[5] 
Inactive CompaniesShireUniversitair Ziekenhuis BrusselUniversity Of Wisconsin-Madison +[5] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Hyperphosphatemia
Inactive IndicationsCalciphylaxisKidney Failure, ChronicRenal Insufficiency, Chronic +[6] 

Other Information

ATC CodeV03AE03
Related LinksWikipediaDrugBankKEGG